Isotretinoin as monotherapy for sebaceous hyperplasia

Journal of Drugs in Dermatology

Volumn 9, Issue 6, 2010, Pages 699-701

  Yu, Clara ^a   Shahsavari, Maryam ^b   Stevens, Gloria ^c   Liskanich, Ronald ^b   Horowitz, David ^b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b WESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID; TAZAROTENE; TRICHLOROACETIC ACID; DERMATOLOGICAL AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CAUTERIZATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG TREATMENT FAILURE; FACE; FEMALE; HUMAN; HYPERPLASIA; LOW LEVEL LASER THERAPY; MEDICAL HISTORY; MONOTHERAPY; MORNING DOSAGE; PHYSICAL EXAMINATION; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; MIDDLE AGED; PATHOLOGY; SEBACEOUS GLAND;

DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYPERPLASIA; ISOTRETINOIN; MIDDLE AGED; SEBACEOUS GLANDS;

EID: 77955856669     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Liu HN, Perry HO. Identifying a common - and benign - geriatric skin lesion. Geriatrics. 1986;41(7):71-73,76.
2. Kato N, Yasuoka A. "Giant" senile sebaceous hyperplasia. J Dermatol. 1992;19(4):238-241.
3. Accessed August 6, 2008.
4. De Villez RL, Roberts LC. Premature sebaceous gland hyperplasia. J Am Acad Dermatol. 1982;6(5):933-935. (Pubitemid 12155267)
5. Marcusson JA, Bjarnason B, Ros AM. Isotretinoin for sebaceous skin lesions in Muir-Torre syndrome: A case report. Acta Derm Venereol. 1998;78(6):479-480. (Pubitemid 28505975)
6. Boschnakow A, May T, Assaf C, et al. Ciclosporin A-induced sebaceous gland hyperplasia. Br J Dermatol. 2003;149(1):198-200. (Pubitemid 36966537)
7. Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors. A sensitive marker of sebaceous differentiation. Am J Dermatopathol. 1999;21(5):426-431. (Pubitemid 29491268)
8. Elder D, Elenitsas R, Ragsdale BD. Tumors of the epidermal appendages. In: Elder D, Elenitas R, Jaworsky C, Johnson B. Lever's Histopathology of Skin. 8th ed. Philadelphia, PA: Lippincott-Raven; 1997:765.
9. Murphy GF, Elder DE. Non-melanocytic tumors of the skin. In: Rosai J, (ed.). Atlas of Tumor Pathology. 3rd series. Washington, DC: Armed Forces Institute of Pathology (AFIP); 1991:127-128.
10. Bader RS, Scarborough DA. Surgical pearl: Intralesional electrodesiccation of sebaceous hyperplasia. J Am Acad Dermatol. 2000;42(1 Pt 1):127.
11. Wheeland RG, Wiley MD. Q-tip cryosurgery for the treatment of senile sebaceous hyperplasia. J Dermatol Surg Oncol. 1987;13:729-730. (Pubitemid 17114179)
12. Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol. 2003;2(5):501-504.
13. Aghassi D, et al. Elucidating the pulsed-dye laser treatment of sebaceous hyperplasia in vivo with real-time confocal scanning laser microscopy. J Am Acad Dermatol. 2000;43(1 Pt 1):49.
14. Rosian R, Goslen JB, Brodell RT. The treatment of benign sebaceous hyperplasia with the topical application of bichloracetic acid. J Dermatol Surg Oncol. 1991;17:876.
15. Zouboulis CC. Isotretinoin revisited: Pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006;126(10):2154-2156. (Pubitemid 44413158)
16. Grekin RC, Ellis CN. Isotretinoin for the treatment of sebaceous hyperplasia. Cutis. 1984;34(1):90-92. (Pubitemid 14086093)
17. Burton CS, Sawchuk WS. Premature sebaceous gland hyperplasia: Successful treatment with isotretinoin. J Am Acad Dermatol. 1985;12:182.
18. Grimalt R, Ferrando J, Mascaro JM. Premature familial sebaceous hyperplasia: Successful response to oral isotretinoin in three patients. J Am Acad Dermatol. 1997;37(6):996-998. (Pubitemid 28016635)